Trade Pfizer ^PFE

Meta, Pfizer on DOL List of Upcoming Contractor Anti-Bias Audits

Pfizer (NYSE:PFE) Stock Price Down 0.6% - Should You Sell?

Pzena Investment Management LLC Boosts Holdings in Pfizer Inc. (NYSE:PFE)

Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief

Pfizer Inc. (NYSE:PFE) Shares Sold by Moors & Cabot Inc.

News Highlights: Top Company News of the Day - Wednesday at 9 AM ET | Morningstar

First Horizon Advisors Inc. Purchases 95,749 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer Names Chris Boshoff Chief Scientific Officer And President, R&D, Effective Jan.1

Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies | Morningstar

Advisors Asset Management Inc. Acquires 28,704 Shares of Pfizer Inc. (NYSE:PFE)

News Highlights: Top Company News of the Day - Wednesday at 7 AM ET | Morningstar

Commerce Bank Has $60.56 Million Stake in Pfizer Inc. (NYSE:PFE)

Pfizer Names Oncology Head Boshoff as Chief Science Officer

Pfizer Gets European Approval of Hympavzi Hemophilia Drug | Morningstar

Pfizer names Chris Boshoff as new R&D chief starting 2025 By Investing.com

Pfizer Inc. (NYSE:PFE) Shares Bought by Pathstone Holdings LLC

Pfizer Inc. (NYSE:PFE) Stake Raised by Thrivent Financial for Lutherans

Pfizer's HYMPAVZI Approved In EU For Treatment Of Severe Hemophilia A Or B Without Inhibitors

StockNews.com Downgrades Pfizer (NYSE:PFE) to Buy

Pfizer names insider Chris Boshoff as R&D chief By Reuters

Pfizer Appoints Chris Boshoff as Chief Scientific Officer and President of R&D By Investing.com

Pfizer Announces EU Approval of HYMPAVZI for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors By Investing.com

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels - November 20, 2024 - Zacks.com

Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan - November 20, 2024 - Zacks.com

5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential - November 20, 2024 - Zacks.com

Pfizer names oncology chief Chris Boshoff as new chief scientific officer | Morningstar

Healthcare Players React To Dr. Oz Joining RFK Jr In Trump Lineup 11/21/2024

Pfizer (NYSE:PFE) Trading Up 0.7% - Here's What Happened

Pfizer Inc. (NYSE:PFE) Shares Acquired by Meeder Advisory Services Inc.

High-Flying Genetics Testing Firm GeneDx Hires Ex-Zoetis GC as Legal Chief

Pfizer Inc. (NYSE:PFE) Holdings Lowered by PNC Financial Services Group Inc.

Pfizer Inc. (NYSE:PFE) Holdings Lowered by Banque Cantonale Vaudoise

Verity & Verity LLC Purchases 108,863 Shares of Pfizer Inc. (NYSE:PFE)

OneAscent Financial Services LLC Invests $739,000 in Pfizer Inc. (NYSE:PFE)

Belmont Capital LLC Has $270,000 Stake in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Holdings Decreased by AMG National Trust Bank

These 4 Price-to-Sales Stocks Can Supercharge Your Portfolio Growth - November 19, 2024 - Zacks.com

The Zacks Analyst Blog Highlights Pfizer, Newmont, Uber, Adobe and Qualcomm - November 19, 2024 - Zacks.com

Antifungal Drugs Market Growth Driven by Rising Fungal Infections Worldwide – Express Press Release Distribution

Global Narcolepsy Treatment Market Set to Reach USD 6.67 Billion by 2028 at a 5.7% of CAGR, Driven by Advancements in Care and Growing Awareness – Express Press Release Distribution

Jim Cramer on Pfizer Inc. (PFE): ‘Still, Anything Good There, It Could Fly’

Pfizer (NYSE:PFE) Stock Price Up 0.6% - Here's What Happened

Jim Cramer Talked About These 11 Stocks Recently

Is Pfizer Inc. (PFE) the Best Immunotherapy Stock to Buy Now?

TrinityPoint Wealth LLC Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)

Vaughan Nelson Investment Management L.P. Has $2.57 Million Position in Pfizer Inc. (NYSE:PFE)

Buy 5 U.S. Bigwigs on the Dip for Sparkling Returns in the Short Term - November 18, 2024 - Zacks.com

FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria - November 18, 2024 - Zacks.com

Pfizer Inc. (NYSE:PFE) Given Average Recommendation of "Moderate Buy" by Brokerages